The authors have published a correction to their previous study on the effects of photobiomodulation in Alzheimer's disease. The correction provides updated information on the mechanisms by which photobiomodulation may suppress the JNK3 pathway and attenuate AMPA receptor endocytosis, potentially leading to improved outcomes in Alzheimer's disease. The authors acknowledge the need for further research to fully understand the complex interplay of signaling pathways involved in this process.
Correction to “Photobiomodulation Suppresses JNK3 by Activation of ERK/MKP7 to Attenuate AMPA Receptor Endocytosis in Alzheimer's Disease”
Informational, non-clinical synthesis informed by published research. Not a clinical guideline or medical advice. May contain errors or editorial interpretation. Consult the original source and your physician.
